Sound Pharmaceuticals

Company Information

Sound Pharmaceuticals (SPI) is a privately held biopharmaceutical company in Seattle, WA.

Sound Pharmaceuticals, Inc. (SPI) is developing therapeutics that will enable doctors and patients to prevent and treat various forms of hearing loss. Sensorineural hearing loss is the third largest disease in the industrialized world and affects 50 million Americans. Estimates from the NIH and the CDC place the total annual costs of hearing loss at approximately $50 billion per year in the U.S. alone.

News Release

Clinical Trials in Meniere's Disease (PDF)

Contact Information

Jonathan Kil, M.D.
jkil@soundpharma.com
Phone: 206-634-2559

Sound Pharmaceuticals Website